Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Joel Beatty is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/18/2024 | ELF | Buy Now | e.l.f. Beauty | $179.65 | 28.03% | $210 → $230 | Upgrade | Neutral → Outperform | Get Alert |
| 07/11/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $35.95 | 66.9% | $36 → $60 | Maintains | Outperform | Get Alert |
| 06/27/2024 | IMMP | Buy Now | Immutep | $1.94 | 209.28% | $7 → $6 | Maintains | Outperform | Get Alert |
| 06/11/2024 | SAGE | Buy Now | Sage Therapeutics | $12.39 | 21.07% | $15 → $15 | Maintains | Neutral | Get Alert |
| 06/11/2024 | NGNE | Buy Now | Neurogene | $41.42 | 30.37% | → $54 | Initiates | → Outperform | Get Alert |
| 05/31/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $42.55 | 69.21% | $68 → $72 | Maintains | Outperform | Get Alert |
| 05/29/2024 | SAGE | Buy Now | Sage Therapeutics | $12.39 | 21.07% | → $15 | Initiates | → Neutral | Get Alert |
| 05/28/2024 | MNMD | Buy Now | Mind Medicine | $7.90 | 241.77% | → $27 | Initiates | → Outperform | Get Alert |
| 05/17/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $84.09 | -14.38% | $104 → $72 | Downgrade | Outperform → Neutral | Get Alert |
| 05/15/2024 | CLDI | Buy Now | Calidi Biotherapeutics | — | — | $45 → $20 | Maintains | Outperform | Get Alert |
| 05/09/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 57.75% | $31 → $28 | Maintains | Outperform | Get Alert |
| 05/07/2024 | AXSM | Buy Now | Axsome Therapeutics | $86.03 | 30.19% | $108 → $112 | Maintains | Outperform | Get Alert |
| 05/01/2024 | PRAX | Buy Now | Praxis Precision Medicine | $54.96 | 112.88% | → $117 | Initiates | → Outperform | Get Alert |
| 05/01/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $35.95 | 0.14% | → $36 | Initiates | → Outperform | Get Alert |
| 04/30/2024 | GERN | Buy Now | Geron | $4.59 | -1.96% | → $4.5 | Downgrade | Outperform → Neutral | Get Alert |
| 04/17/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $73.03 | 41.04% | $83 → $103 | Maintains | Outperform | Get Alert |
| 04/11/2024 | NRIX | Buy Now | Nurix Therapeutics | $20.78 | 20.31% | $24 → $25 | Maintains | Outperform | Get Alert |
| 04/11/2024 | AMLX | Buy Now | Amylyx Pharma | $1.99 | 50.75% | $4 → $3 | Maintains | Neutral | Get Alert |
| 03/21/2024 | CLDI | Buy Now | Calidi Biotherapeutics | — | — | $90 → $45 | Maintains | Outperform | Get Alert |
| 03/19/2024 | LPTX | Buy Now | Leap Therapeutics | $2.20 | 309.09% | $11 → $9 | Maintains | Outperform | Get Alert |
| 03/19/2024 | ALKS | Buy Now | Alkermes | $24.83 | 49.01% | → $37 | Initiates | → Outperform | Get Alert |
| 03/19/2024 | AXSM | Buy Now | Axsome Therapeutics | $86.03 | 25.54% | → $108 | Initiates | → Outperform | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 74.65% | $40 → $31 | Maintains | Outperform | Get Alert |
| 03/11/2024 | AMLX | Buy Now | Amylyx Pharma | $1.99 | 101.01% | $37 → $4 | Downgrade | Outperform → Neutral | Get Alert |
| 03/01/2024 | ARGX | Buy Now | argenx | $471.32 | 3.96% | $505 → $490 | Maintains | Outperform | Get Alert |
| 02/26/2024 | COGT | Buy Now | Cogent Biosciences | $8.61 | -7.08% | $14 → $8 | Downgrade | Outperform → Neutral | Get Alert |
| 01/30/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $42.55 | 59.81% | $57 → $68 | Maintains | Outperform | Get Alert |
| 01/30/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $84.09 | 23.68% | $127 → $104 | Maintains | Outperform | Get Alert |
| 01/30/2024 | ELF | Buy Now | e.l.f. Beauty | $179.65 | 2.98% | → $185 | Initiates | → Neutral | Get Alert |
| 01/30/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 125.35% | → $40 | Initiates | → Outperform | Get Alert |
| 01/16/2024 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $28 | Downgrade | Outperform → Neutral | Get Alert |
| 01/03/2024 | AMLX | Buy Now | Amylyx Pharma | $1.99 | 1759.3% | → $37 | Initiates | → Outperform | Get Alert |
| 01/03/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $109.01 | 46.78% | → $160 | Initiates | → Outperform | Get Alert |
| 01/03/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $73.03 | 13.65% | → $83 | Initiates | → Outperform | Get Alert |
| 10/09/2023 | CLDI | Buy Now | Calidi Biotherapeutics | — | — | → $90 | Initiates | → Outperform | Get Alert |
| 09/08/2023 | VAXX | Buy Now | Vaxxinity | $0.10 | 6900% | → $7 | Initiates | → Outperform | Get Alert |
| 08/28/2023 | IMMP | Buy Now | Immutep | $1.94 | 260.82% | → $7 | Reiterates | Outperform → Outperform | Get Alert |
| 08/15/2023 | LPTX | Buy Now | Leap Therapeutics | $2.20 | 809.09% | $30 → $20 | Maintains | Outperform | Get Alert |
| 08/15/2023 | TCON | Buy Now | TRACON Pharma | $0.68 | 342.35% | $140 → $60 | Maintains | Outperform | Get Alert |
| 08/03/2023 | IMMP | Buy Now | Immutep | $1.94 | 260.82% | → $7 | Initiates | → Outperform | Get Alert |
| 08/02/2023 | IMMP | Buy Now | Immutep | $1.94 | 260.82% | → $7 | Initiates | → Outperform | Get Alert |
| 06/30/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $84.09 | 51.03% | → $127 | Reiterates | Outperform → Outperform | Get Alert |
| 06/01/2023 | INMB | Buy Now | INmune Bio | $8.08 | 98.02% | → $16 | Initiates | → Outperform | Get Alert |
| 05/23/2023 | CMRX | Buy Now | Chimerix | $0.94 | 644.68% | → $7 | Initiates | → Outperform | Get Alert |
| 05/11/2023 | TCON | Buy Now | TRACON Pharma | $0.68 | 932.14% | $160 → $140 | Maintains | Outperform | Get Alert |
| 05/02/2023 | BYSI | Buy Now | BeyondSpring | $2.20 | -43.18% | $4 → $1.25 | Maintains | Outperform | Get Alert |
| 04/28/2023 | COGT | Buy Now | Cogent Biosciences | $8.61 | 132.29% | → $20 | Initiates | → Outperform | Get Alert |
| 04/27/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $84.09 | 51.03% | $112 → $127 | Maintains | Outperform | Get Alert |
| 04/13/2023 | PLRX | Buy Now | Pliant Therapeutics | $12.08 | 264.24% | → $44 | Initiates | → Outperform | Get Alert |
| 04/05/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | $11 → $12 | Maintains | Outperform | Get Alert |
| 02/17/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $42.55 | 33.96% | $50 → $57 | Maintains | Outperform | Get Alert |
| 02/07/2023 | ARWR | Buy Now | Arrowhead Pharma | $28.30 | 104.95% | $60 → $58 | Maintains | Outperform | Get Alert |
| 11/18/2022 | IDYA | Buy Now | IDEAYA Biosciences | $40.89 | -41.31% | $18 → $24 | Maintains | Outperform | Get Alert |
| 11/18/2022 | EDIT | Buy Now | Editas Medicine | $5.10 | 252.94% | $25 → $18 | Maintains | Outperform | Get Alert |
| 11/10/2022 | ARCT | Buy Now | Arcturus Therapeutics | $23.79 | -24.34% | → $18 | Downgrade | Neutral → Underperform | Get Alert |
| 11/03/2022 | EDIT | Buy Now | Editas Medicine | $5.10 | 390.2% | $30 → $25 | Maintains | Outperform | Get Alert |
| 11/03/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $42.55 | 17.51% | $63 → $50 | Upgrade | Neutral → Outperform | Get Alert |
| 08/29/2022 | CRDF | Buy Now | Cardiff Oncology | $2.36 | 154.24% | $9 → $6 | Maintains | Outperform | Get Alert |
| 08/16/2022 | IDYA | Buy Now | IDEAYA Biosciences | $40.89 | -55.98% | $26 → $18 | Maintains | Outperform | Get Alert |
| 07/29/2022 | ARGX | Buy Now | argenx | $471.32 | -2.4% | $374 → $460 | Downgrade | Outperform → Neutral | Get Alert |
| 07/08/2022 | NRIX | Buy Now | Nurix Therapeutics | $20.78 | 53.99% | $41 → $32 | Maintains | Outperform | Get Alert |
| 06/01/2022 | IGMS | Buy Now | IGM Biosciences | $11.25 | 175.56% | $46 → $31 | Maintains | Outperform | Get Alert |
| 05/11/2022 | ARWR | Buy Now | Arrowhead Pharma | $28.30 | 112.01% | $71 → $60 | Upgrade | Neutral → Outperform | Get Alert |
| 05/11/2022 | ARCT | Buy Now | Arcturus Therapeutics | $23.79 | -24.34% | $21 → $18 | Upgrade | Underperform → Neutral | Get Alert |
| 04/07/2022 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $16 | Initiates | → Outperform | Get Alert |
| 04/04/2022 | IGMS | Buy Now | IGM Biosciences | $11.25 | 308.89% | $65 → $46 | Maintains | Outperform | Get Alert |
| 03/03/2022 | VIR | Buy Now | Vir Biotechnology | $10.03 | 179.16% | $36 → $28 | Upgrade | Underperform → Neutral | Get Alert |
| 02/23/2022 | TCON | Buy Now | TRACON Pharma | $0.68 | 1374.49% | → $200 | Initiates | → Outperform | Get Alert |
| 12/21/2021 | VIR | Buy Now | Vir Biotechnology | $10.03 | 258.92% | → $36 | Downgrade | Neutral → Underperform | Get Alert |
| 12/08/2021 | CRDF | Buy Now | Cardiff Oncology | $2.36 | 705.08% | — | Initiates | → Outperform | Get Alert |
| 04/06/2020 | DBVT | Buy Now | DBV Technologies | $0.87 | 1049.43% | $28 → $20 | Maintains | Buy | Get Alert |
| 12/16/2019 | DBVT | Buy Now | DBV Technologies | $0.87 | 1509.2% | → $28 | Initiates | → Buy | Get Alert |
